KR20180128025A - 지용성 활성 성분을 포함하는 나노캡슐, 그 제조 방법 및 그 용도 - Google Patents

지용성 활성 성분을 포함하는 나노캡슐, 그 제조 방법 및 그 용도 Download PDF

Info

Publication number
KR20180128025A
KR20180128025A KR1020187030631A KR20187030631A KR20180128025A KR 20180128025 A KR20180128025 A KR 20180128025A KR 1020187030631 A KR1020187030631 A KR 1020187030631A KR 20187030631 A KR20187030631 A KR 20187030631A KR 20180128025 A KR20180128025 A KR 20180128025A
Authority
KR
South Korea
Prior art keywords
ionic surfactant
nanocapsule
nanocapsules
vitamin
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020187030631A
Other languages
English (en)
Korean (ko)
Inventor
다미앙 프레베로드
베로니크 로질리오
Original Assignee
아디쎄오 프랑스 에스에이에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아디쎄오 프랑스 에스에이에스 filed Critical 아디쎄오 프랑스 에스에이에스
Publication of KR20180128025A publication Critical patent/KR20180128025A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Colloid Chemistry (AREA)
  • Fodder In General (AREA)
  • General Preparation And Processing Of Foods (AREA)
KR1020187030631A 2016-03-25 2017-03-17 지용성 활성 성분을 포함하는 나노캡슐, 그 제조 방법 및 그 용도 Ceased KR20180128025A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1652592 2016-03-25
FR16/52592 2016-03-25
PCT/FR2017/050622 WO2017162963A1 (fr) 2016-03-25 2017-03-17 Nanocapsules de principe actif liposoluble, fabrication et utilisations

Publications (1)

Publication Number Publication Date
KR20180128025A true KR20180128025A (ko) 2018-11-30

Family

ID=56263861

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187030631A Ceased KR20180128025A (ko) 2016-03-25 2017-03-17 지용성 활성 성분을 포함하는 나노캡슐, 그 제조 방법 및 그 용도

Country Status (14)

Country Link
US (1) US10765639B2 (enExample)
EP (1) EP3432729B1 (enExample)
JP (1) JP2019513359A (enExample)
KR (1) KR20180128025A (enExample)
CN (1) CN108882729A (enExample)
AU (1) AU2017236312B2 (enExample)
BR (1) BR112018069392B1 (enExample)
CA (1) CA3017931C (enExample)
ES (1) ES3040905T3 (enExample)
MX (1) MX2018011620A (enExample)
RU (1) RU2745844C2 (enExample)
UA (1) UA127243C2 (enExample)
WO (1) WO2017162963A1 (enExample)
ZA (1) ZA201806197B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210065708A (ko) * 2019-11-27 2021-06-04 군산대학교산학협력단 유자 오일을 포함하는 나노복합체의 제조방법

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2736051C1 (ru) * 2020-03-04 2020-11-11 Александр Александрович Кролевец Способ получения нанокапсул сухого экстракта эхинацеи
RU2743010C1 (ru) * 2020-03-23 2021-02-12 Таисия Скандарбековна Гутнова Способ получения нанокапсул витамина D3
CN114847488A (zh) * 2022-05-17 2022-08-05 江南大学 一种高稳定性和生物可给率的橘味维生素a-维生素d纳米复合载体制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788007B1 (fr) * 1999-01-05 2001-02-09 Oreal Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
FR2803203B1 (fr) 1999-12-31 2002-05-10 Fournier Ind & Sante Nouvelles formulations galeniques du fenofibrate
FR2806005B1 (fr) * 2000-03-10 2002-06-14 Univ Claude Bernard Lyon Procede de preparation de particules colloidales sous forme de nanocapsules
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
JP2005028559A (ja) * 2003-07-08 2005-02-03 Shinobu Ito ナノカプセル
FR2864900B1 (fr) * 2004-01-09 2007-10-12 Oreal Dispersion aqueuse de nanocapsules a coeur huileux
US8877217B2 (en) * 2005-10-18 2014-11-04 Amorepacific Corporation Cationic polymer nanoparticles encapsulating an active ingredients, and the cosmetic composition containing the same
ATE515260T1 (de) * 2006-03-13 2011-07-15 Advanced In Vitro Cell Technologies S L Stabile nanokapselsysteme für die verabreichung von wirkstoffen
FR2924943A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition dermatologique comprenant des nanocapsules polymeriques de calcitriol, son procede de preparation et son utilisation
BRPI0805854A2 (pt) * 2008-10-10 2010-08-24 Biolab Sanus Farmaceutica Ltda sistema nanoparticulado, processo de preparaÇço do mesmo, uso do mesmo, composiÇço fotoproterora, processo de preparaÇço da mesma, mÉtodo de prevenÇço de doenÇas e distérbios da pele
NZ595984A (en) * 2009-04-24 2014-04-30 Iceutica Pty Ltd Production of encapsulated nanoparticles at commercial scale
EP2266546A1 (en) * 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Process for the preparation of colloidal systems for the delivery of active compounds
ES2351756B1 (es) * 2009-07-28 2011-10-05 Universidad Del Pais Vasco Nanopartículas lipídicas para terapia génica.
US20150231069A1 (en) * 2014-02-20 2015-08-20 Pankaj Modi Oral formulations of chemotherapeutic agents
RU2557900C1 (ru) * 2014-03-25 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул витаминов
US10391060B2 (en) * 2015-08-06 2019-08-27 Rubicon Research Private Limited Particulate delivery systems

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210065708A (ko) * 2019-11-27 2021-06-04 군산대학교산학협력단 유자 오일을 포함하는 나노복합체의 제조방법

Also Published As

Publication number Publication date
CA3017931A1 (fr) 2017-09-28
RU2745844C2 (ru) 2021-04-01
JP2019513359A (ja) 2019-05-30
US10765639B2 (en) 2020-09-08
RU2018135575A (ru) 2020-04-27
BR112018069392B1 (pt) 2022-11-22
MX2018011620A (es) 2019-03-14
AU2017236312A1 (en) 2018-10-18
ES3040905T3 (en) 2025-11-05
RU2018135575A3 (enExample) 2020-06-09
ZA201806197B (en) 2019-06-26
US20190083414A1 (en) 2019-03-21
CN108882729A (zh) 2018-11-23
EP3432729B1 (fr) 2025-08-13
EP3432729A1 (fr) 2019-01-30
BR112018069392A2 (pt) 2019-01-22
UA127243C2 (uk) 2023-06-21
AU2017236312B2 (en) 2021-02-04
WO2017162963A1 (fr) 2017-09-28
CA3017931C (fr) 2024-01-09

Similar Documents

Publication Publication Date Title
AU2008340061B2 (en) Microcapsules comprising a fat -soluble active substance
CN106659230B (zh) 疏水性生物活性化合物的包封
CN109288065A (zh) 一种负载脂溶性维生素的悬浮乳液凝胶及其制备方法
KR102170339B1 (ko) 신규 코팅 시스템
WO2015169816A1 (en) Formulation of fat-soluble vitamin
KR20180128025A (ko) 지용성 활성 성분을 포함하는 나노캡슐, 그 제조 방법 및 그 용도
CN102552058A (zh) 复合维生素脂质纳米粒及其制备方法
CN103635181A (zh) 磷脂酰丝氨酸的微胶囊化方法
EP1736532A1 (en) Method for producing calcium component powder containing oil-soluble substance
Contreras-López et al. Microencapsulation of feed additives with potential in livestock and poultry production: A systematic review
CN113208141A (zh) 用于生产离散固体挤出颗粒的方法
JP6954917B2 (ja) 多相活性物質調製物
JP6464745B2 (ja) 生理活性物質の担持力を向上させたナノ粒子の製造方法
CN111358000B (zh) 含有胡萝卜素的油性组合物
JP2011240221A (ja) 脂溶性機能性化合物エマルション及びその製造方法
JP6443009B2 (ja) 生理活性物質の担持力を向上させたナノ粒子の製造方法
Pineda et al. Nanoencapsulation of Hydrophobic Compounds in Milk

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20181023

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200312

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20211117

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20220405

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20211117

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20220405

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20220114

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220617

Patent event code: PE09021S01D

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20230221

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20220617

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20220602

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20220405

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20220114

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20211117

X601 Decision of rejection after re-examination